Showing results (81-90 of 111) with videos related to
Sort By:
Pageof 12
Hepatology (Baltimore, Md.)|November 24, 2019
Major Vault Protein Promotes Hepatocellular Carcinoma Through Targeting Interferon Regulatory Factor 2 and Decreasing p53 ActivityHaisheng Yu, Mengqi Li, Rui He, et al.Frontiers in Immunology|July 5, 2021
Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom OnsetTiandan Xiang, Boyun Liang, Yaohui Fang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2023
HLA Class II Loss and JAK1/2 Deficiency Coevolve in Melanoma Leading to CD4 T-cell and IFNγ Cross-ResistanceSimone Stupia, Christina Heeke, Alicia Brüggemann, et al.BMC Genomics|June 29, 2024
UnCoVar: a reproducible and scalable workflow for transparent and robust virus variant calling and lineage assignment using SARS-CoV-2 as an exampleAlexander Thomas, Thomas Battenfeld, Ivana Kraiselburd, et al.European Journal of Immunology|October 17, 2022
Acute cytomegalovirus infection modulates the intestinal microbiota and targets intestinal epithelial cellsVu Thuy Khanh Le-Trilling, Jana-Fabienne Ebel, Franziska Baier, et al.Frontiers in Immunology|January 10, 2022
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World SettingZiwei Li, Tiandan Xiang, Boyun Liang, et al.Cancers|February 13, 2026
COVID-19 and Influenza Booster Vaccination Elicits Robust Antibody Responses in Patients with Primary Brain Tumors Comparable to Healthy AdultsTeresa Schmidt, Mirko Trilling, Vu Thuy Khanh Le-Trilling, et al.BMC Biology|November 29, 2022
Identification of herbal teas and their compounds eliciting antiviral activity against SARS-CoV-2 in vitroVu Thuy Khanh Le-Trilling, Denise Mennerich, Corinna Schuler, et al.Mbio|September 19, 2020
Impaired Cytotoxic CD8<sup>+</sup> T Cell Response in Elderly COVID-19 PatientsJaana Westmeier, Krystallenia Paniskaki, Zehra Karaköse, et al.Frontiers in Immunology|January 25, 2024
Persistence of KIR<sup>neg</sup> NK cells after haploidentical hematopoietic stem cell transplantation protects from human cytomegalovirus infection/reactivationClara Di Vito, Nicolò Coianiz, Michela Calvi, et al.Pageof 12